Oncotelic's Patented Lead Anti-Cancer Drug Candidate as Well as Drug Delivery Platform for Brain Tumors on Track for Advanced Pivotal Phase 3 Clinical Testing

Stock Information for Mateon Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.